Hemostemix Inc. is filing a Form 4B to secure price protection for the closing of the third tranche of its $1 million non-brokered private placement. The offering includes units composed of common shares and warrants, with proceeds aimed at advancing sales, marketing, production, and regulatory efforts for its autologous stem cell therapy products, including ACP-01. This financing supports Hemostemix's ongoing clinical research and commercialization initiatives for treatments targeting ischemic diseases. The offering is pending final approval from the TSX Venture Exchange.
Hemostemix's private placement news is presented alongside Pluang's health sector market data. As of Sep 24, 2026 03:02 WIB, 37 out of 100 health-sector US stocks on Pluang rose while 63 fell. Notable movers include ClearPoint Neuro Inc (CLPT) at USD 14.86 with a 1-day change of -5.89%, Quest Diagnostics Inc (DGX) at USD 232.90 down 5.51%, and Crispr Therapeutics AG (CRSP) at USD 55.90 down 5.30%.
Costco Wholesale announced $93.9 billion in net sales for its fiscal Q4, up 11.3% from last year, with comparable sales rising 9.4%. The full earnings report on September 24 will reveal membership fees, total revenue, expenses, and profit details. An...
Jefferies reaffirmed its Buy rating on Life Time Group Holdings (LTH), citing a positive earnings outlook supported by a Zacks Rank of #2. The stock trades around $38.85 with a market cap near $8.68 billion. Despite this optimism, Executive Vice Pres...
Vanguard's International Dividend Appreciation ETF (VIGI) mirrors the popular U.S. dividend growth ETF (VIG) but invests globally, offering a 44% higher yield. While VIG focuses on U.S. companies with a long history of dividend increases, VIGI target...
Coeur Mining Inc., a U.S.-based precious metals producer with operations across North America, officially celebrated its new listing on the Toronto Stock Exchange (TSX). The company's Chairman and CEO, Mitchell J. Krebs, along with other executives, ...
Miivo AI Inc. announced its participation in the Muskoka Capital Event from September 25-27, 2026, where it will hold 18 scheduled meetings with institutional investors and high-net-worth individuals. The event aims to foster long-term capital relati...
